Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimizing Pediatric Medicine Developments in the European Union Through Pragmatic Approaches.
Rei Bolislis W, Bejeuhr G, Benzaghou F, Corriol-Rohou S, Herrero-Martinez E, Hildebrand H, Hill-Venning C, Hoogland H, Johnson C, Joos A, Vart R, Le Visage G, Kühler TC. Rei Bolislis W, et al. Among authors: hildebrand h. Clin Pharmacol Ther. 2021 Oct;110(4):871-879. doi: 10.1002/cpt.2152. Epub 2021 Feb 2. Clin Pharmacol Ther. 2021. PMID: 33411346 Free PMC article.
The conect4children (c4c) Consortium: Potential for Improving European Clinical Research into Medicines for Children.
Turner MA, Hildebrand H, Fernandes RM, de Wildt SN, Mahler F, Hankard R, Leary R, Bonifazi F, Nobels P, Cheng K, Attar S, Rossi P, Rocchi F, Claverol J, Nafria B, Giaquinto C. Turner MA, et al. Among authors: hildebrand h. Pharmaceut Med. 2021 Mar;35(2):71-79. doi: 10.1007/s40290-020-00373-6. Epub 2021 Feb 4. Pharmaceut Med. 2021. PMID: 33539007 Free PMC article.
European research networks to facilitate drug research in children.
Turner MA, Cheng K, de Wildt S, Hildebrand H, Attar S, Rossi P, Bonifazi D, Ceci A, Claverol J, Nafria B, Giaquinto C. Turner MA, et al. Among authors: hildebrand h. Br J Clin Pharmacol. 2022 Oct;88(10):4258-4266. doi: 10.1111/bcp.14545. Epub 2020 Sep 20. Br J Clin Pharmacol. 2022. PMID: 32893382 Free PMC article. Review.
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma.
Vithayathil M, D'Alessio A, Fulgenzi CAM, Nishida N, Schönlein M, von Felden J, Schulze K, Wege H, Saeed A, Wietharn B, Hildebrand H, Wu L, Ang C, Marron TU, Weinmann A, Galle PR, Bettinger D, Bengsch B, Vogel A, Balcar L, Scheiner B, Lee PC, Huang YH, Amara S, Muzaffar M, Naqash AR, Cammarota A, Zanuso V, Pressiani T, Pinter M, Cortellini A, Kudo M, Rimassa L, Pinato DJ, Sharma R. Vithayathil M, et al. Among authors: hildebrand h. Hepatol Int. 2023 Aug;17(4):904-914. doi: 10.1007/s12072-023-10491-3. Epub 2023 Apr 1. Hepatol Int. 2023. PMID: 37005953 Free PMC article.
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
Talbot T, D'Alessio A, Pinter M, Balcar L, Scheiner B, Marron TU, Jun T, Dharmapuri S, Ang C, Saeed A, Hildebrand H, Muzaffar M, Fulgenzi CAM, Amara S, Naqash AR, Gampa A, Pillai A, Wang Y, Khan U, Lee PC, Huang YH, Bengsch B, Bettinger D, Mohamed YI, Kaseb A, Pressiani T, Personeni N, Rimassa L, Nishida N, Kudo M, Weinmann A, Galle PR, Muhammed A, Cortellini A, Vogel A, Pinato DJ. Talbot T, et al. Among authors: hildebrand h. Liver Int. 2023 Mar;43(3):695-707. doi: 10.1111/liv.15502. Epub 2023 Jan 13. Liver Int. 2023. PMID: 36577703 Free PMC article.
247 results